Skip to main content
Clinical Trials/NCT01294514
NCT01294514CompletedNot Applicable

Novel Cardio-Respiratory Parameter in Healthy Volunteers

Medtronic - MITG1 site in 1 country27 target enrollmentStarted: February 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
27
Locations
1
Primary Endpoint
The Covidien Nellcor Respiration Rate Software Shall Determine Respiration Rate Measured as Mean and Standard Deviation With Accuracy That is Non-inferior to Predicate Device.

Study Overview

Brief Summary

The purpose of this study is to study Non-Invasive Performance evaluation of monitoring algorithm.

Detailed Description

Assess equivalency, performance, and accuracy of a new monitoring algorithm in Healthy Volunteers.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subject is 18 or older
  • Subject is willing and able to provide written consent

Exclusion Criteria

  • Severe contact allergies to standard adhesive materials
  • Subjects with abnormalities that may prevent proper application of the device
  • Women who are pregnant or lactating
  • Subjects with significant Arrhythmias

Outcomes

Primary Outcomes

The Covidien Nellcor Respiration Rate Software Shall Determine Respiration Rate Measured as Mean and Standard Deviation With Accuracy That is Non-inferior to Predicate Device.

Time Frame: Participants were monitorerd on average of 30 minute period

Mean and standard deviations of respiration rates collected from healthy volunteers were compared between Covidien Respiration Rate Software, Transthoracic Impedance and Overscored End-Tidal Carbon Dioxide Waveforms. Each volunteer served as its own control.

Secondary Outcomes

  • The Covidien Nellcor Respiration Rate Software Shall Calculate Respiration Rate With a Root Mean Square Difference (RMSD) of < 3 Breaths Per Minute Compared With a End-Tidal Carbon Dioxide Waveforms, With 95% Confidence.(Participants were monitored on average of 30 minute periods)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials